Inventor · disambiguated record
Juan Fueyo-Margareto
Also filed as: FUEYO-MARGARETO JUAN
5 granted patents·7 pending applications·11 citations·filing 2013–2024
72Inventor score
Top patents by PatentIndex Score
12 records- 0185US10391183B2Infectivity-enhanced conditionally-replicative adenovirus and uses thereofUNIV TEXAS·Filed 2014·Granted Aug 27, 2019·8 cites·8 claims
- 0282US2025171745A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2024·Application pending·0 cites
- 0374US11155599B2Adenoviruses expressing heterologous tumor-associated antigensUNIV TEXAS·Filed 2013·Granted Oct 26, 2021·1 cites·17 claims
- 0473US11090344B2Adenovirus and immunomodulator combination therapyDNATRIX INC·Filed 2017·Granted Aug 17, 2021·1 cites·14 claims
- 0568US2021301264A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2021·Application pending·0 cites
- 0667US11065285B2Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2020·Granted Jul 20, 2021·0 cites·14 claims
- 0761US10238698B2Biomarkers and combination therapies using oncolytic virus and immunomodulationDNA TRIX INC·Filed 2013·Granted Mar 26, 2019·1 cites·6 claims
- 0860US2021213079A1Treatment of brain cancer with oncolytic adenovirusDNATRIX INC·Filed 2021·Application pending·0 cites
- 0958US2016289645A1Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)DNATRIX INC·Filed 2014·Application pending·0 cites
- 1056US2019093085A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2018·Application pending·0 cites
- 1152US2019269744A1Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2019·Application pending·0 cites
- 1247US2016143967A1Treatment of brain cancer with oncolytic adenovirusDNATRIX INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Juan Fueyo-Margareto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →